Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Levodopa Induced Dyskinesia”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02617017
What this trial is testing

Buspirone Treatment of Iatrogenic Dyskinesias in Advanced Parkinson' Disease

Who this might be right for
Parkinson
Assistance Publique - Hôpitaux de Paris 99
Early research (Phase 1)Study completedNCT05435729
What this trial is testing

A Pharmacodynamics and Safety Study of DSP-9632P in Patients With Levodopa-Induced Dyskinesia in Parkinson's Disease

Who this might be right for
Levodopa-induced DyskinesiaParkinson's Disease
Sumitomo Pharma Co., Ltd. 7
Testing effectiveness (Phase 2)Study completedNCT01767129
What this trial is testing

Safety and Efficacy of AVP-923 in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients

Who this might be right for
DyskinesiaParkinson's Disease
Avanir Pharmaceuticals 14
Not applicableStudy completedNCT00912977
What this trial is testing

Prospective Evaluation of Forceplate Measured Levodopa-Induced Dyskinesia

Who this might be right for
Parkinson's Disease
Oregon Health and Science University 10
Testing effectiveness (Phase 2)Study completedNCT05297201
What this trial is testing

Efficacy, Safety and Pharmacokinetic Study of CPL500036 in Patients with Levodopa Induced Dyskinesia

Who this might be right for
Parkinson DiseaseDyskinesia, Medication-Induced
Celon Pharma SA 105
Testing effectiveness (Phase 2)Study completedNCT02439203
What this trial is testing

Efficacy and Safety of JM-010 in PD With Levodopa-Induced Dyskinesia

Who this might be right for
Parkinson's DiseaseLevodopa Induced Dyskinesia (LID)
Bukwang Pharmaceutical 30
Testing effectiveness (Phase 2)Study completedNCT00036296
What this trial is testing

Effects of Talampanel on Patients With Advanced Parkinson's Disease

Who this might be right for
DyskinesiasParkinson DiseaseMovement Disorders
Teva Branded Pharmaceutical Products R&D, Inc. 22
Testing effectiveness (Phase 2)Study completedNCT03162874
What this trial is testing

Study to Evaluate the Efficacy, Safety and Tolerability of PXT002331 (Foliglurax) in Reducing Motor Complications of Levodopa Therapy in Parkinson Disease's Patients

Who this might be right for
Parkinson Disease
Prexton Therapeutics 157
Post-approval studies (Phase 4)Study completedNCT00632762
What this trial is testing

Long-Term Effects of Amantadine in Parkinsonian (AMANDYSK)

Who this might be right for
Parkinson's Disease
University Hospital, Toulouse 80
Testing effectiveness (Phase 2)Study completedNCT03531060
What this trial is testing

A Clinical Study of IRL790 in Patients With Parkinson's Disease Experiencing Levodopa Induced Dyskinesia

Who this might be right for
Parkinson Disease
Integrative Research Laboratories AB 15
Not applicableWithdrawnNCT01003002
What this trial is testing

Natural History of Levodopa-Induced Dyskinesia (LID)

Who this might be right for
Parkinson's Disease
Oregon Health and Science University
Testing effectiveness (Phase 2)Study completedNCT01474421
What this trial is testing

Safety and Efficacy of AQW051 in L-dopa Induced Dyskinesias in Patients With Parkinson's Disease

Who this might be right for
DyskinesiasDrug-induced
Novartis Pharmaceuticals 71
Not applicableActive Not RecruitingNCT06240624
What this trial is testing

Mapping Levodopa Effects on Cortico-basal Ganglia Circuit Function in Parkinson's Disease

Who this might be right for
Parkinson Disease
Danish Research Centre for Magnetic Resonance 75
Large-scale testing (Phase 3)Ended earlyNCT02153632
What this trial is testing

Efficacy and Safety of Amantadine Hydrogen Chloride (HCl) ER Tablets in Parkinson's Disease Subjects With LID

Who this might be right for
Parkinson's DiseaseLevodopa Induced Dyskinesia (LID)
Adamas Pharmaceuticals, Inc. 135
Testing effectiveness (Phase 2)Study completedNCT00582673
What this trial is testing

Efficacy and Safety of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Disease Patients, and Safety in Combination With L-dopa

Who this might be right for
Parkinson's Disease
Novartis 31
Not applicableUnknownNCT05752240
What this trial is testing

Transcranial Direct Current Stimulation of the Primary Motor Cortex to Treat Levodopa-induced Dyskinesias

Who this might be right for
Parkinson Disease
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 32
Testing effectiveness (Phase 2)Study completedNCT01113320
What this trial is testing

Safinamide in Levodopa Induced Dyskinesia in Parkinson's Disease Subjects

Who this might be right for
Parkinson's Disease
Newron Pharmaceuticals SPA 26
Large-scale testing (Phase 3)Study completedNCT01397422
What this trial is testing

Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)

Who this might be right for
DyskinesiaLevodopa Induced DyskinesiaParkinson's Disease
Adamas Pharmaceuticals, Inc. 83
Testing effectiveness (Phase 2)UnknownNCT02439125
What this trial is testing

Efficacy and Safety of Eltoprazine HCl for Treating Levodopa-induced Dyskinesia in Parkinson's Disease Patients

Who this might be right for
Parkinson's DiseaseDyskinesia
Amarantus BioScience Holdings, Inc. 60
Not applicableUnknownNCT04173845
What this trial is testing

Double Randomized and Placebo Controlled Trail of Tianqi Pingchan Granule to Prevent Levodopa-Induced Dyskinesia

Who this might be right for
Levodopa-Induced Dyskinesia
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 150
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation